184 ADSCaN: A Randomised Phase II Study of Accelerated, Dose Escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer. Trial Registration Number: ISRCTN47674500
Lung Cancer(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Lung Cancer(2025)